Cite
APA Citation
Geyer, C., Tang, G., Mamounas, E., Rastogi, P., Paik, S., Shak, S., Baehner, F., Crager, M., Wickerham, D., Costantino, J., & Wolmark, N. (2018). 21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer. NPJ breast cancer, 4, 1–6. http://access.bl.uk/ark:/81055/vdc_100086847539.0x000114